APA (7th ed.) Citation

Liao, Y., Tsai, C., & Huang, H. (2025). Optimizing Osimertinib for NSCLC: Targeting Resistance and Exploring Combination Therapeutics. Cancers, 17(3), 459. https://doi.org/10.3390/cancers17030459

Chicago Style (17th ed.) Citation

Liao, Yan-You, Chia-Luen Tsai, and Hsiang-Po Huang. "Optimizing Osimertinib for NSCLC: Targeting Resistance and Exploring Combination Therapeutics." Cancers 17, no. 3 (2025): 459. https://doi.org/10.3390/cancers17030459.

MLA (9th ed.) Citation

Liao, Yan-You, et al. "Optimizing Osimertinib for NSCLC: Targeting Resistance and Exploring Combination Therapeutics." Cancers, vol. 17, no. 3, 2025, p. 459, https://doi.org/10.3390/cancers17030459.